GMO strengthens equities line-up
Global investment management firm GMO has appointed three senior investment professionals to its Sydney-based Australian equities team.
Geoff Wells, Mark Thompson and Bradley Grehan are intended to “strengthen GMO’s global portfolio management, research and trading efforts”, according to GMO’s head of Australian equities Rick Suvak.
Formerly a senior portfolio manager at Macquarie Investment Management, Wells has been appointed as a senior quantitative research analyst, focusing primarily on alpha model research.
Thompson has also joined GMO as senior quantitative research analyst, and will also be concentrating on alpha model research.
He was previously a quantitative portfolio manager at State Street Global Advisors where he managed the group’s short enabled strategies (market-neutral, equitised long-short and 130/30 portfolios).
Grehan joins GMO as a senior portfolio trader, and will focus on trade execution while also participating in the management of GMO’s Australian equity portfolios.
He brings 12 years of industry and trading experience to GMO from Tolhurst, Morgan Stanley and JBWere.
Recommended for you
Pitcher Partners has urged caution about the use of private credit funds, despite a widespread push by fund managers on the benefits of the products.
Just one day after Selfwealth received a “highly attractive” acquisition bid from Bell Financial Group, it has received a second non-binding indicative proposal from a rival.
With nearly one-third of financial advisers utilising Australian Ethical’s investment options, expanding its advised channels remains a key focus for the firm.
The firm has looked overseas to tap Lucinda Hill for the newly created role of executive general manager, product and operations, as it looks to expand into the US.
